These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 33073939)

  • 1. COVID-19 PCR Test, Cluster of False Positive and Importance of Quality Control.
    Joob B; Wiwantikit V
    Clin Lab; 2020 Oct; 66(10):. PubMed ID: 33073939
    [No Abstract]   [Full Text] [Related]  

  • 2. The utility of beta-2-microglobulin testing as a human cellular control in COVID-19 testing.
    Davies E; Whitfield T; Machin N; Ahmad S
    J Clin Virol; 2020 Aug; 129():104449. PubMed ID: 32504943
    [No Abstract]   [Full Text] [Related]  

  • 3. Selecting a SARS-CoV-2/COVID Molecular Testing Method for Your Laboratory.
    Greene DN
    J Appl Lab Med; 2020 Jul; 5(4):837-840. PubMed ID: 32761155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is reinfection possible after recovery from COVID-19?
    Law SK; Leung AWN; Xu C
    Hong Kong Med J; 2020 Jun; 26(3):264-265. PubMed ID: 32536614
    [No Abstract]   [Full Text] [Related]  

  • 5. [Which sampling method for the upper respiratory tract specimen should be taken to diagnose patient with COVID-19?].
    Ye B; Fan C; Pan Y; Ding R; Hu HX; Xiang ML
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jun; 55(6):583-588. PubMed ID: 32166939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covid-19 Molecular Diagnostic Testing - Lessons Learned.
    Shuren J; Stenzel T
    N Engl J Med; 2020 Oct; 383(17):e97. PubMed ID: 32905667
    [No Abstract]   [Full Text] [Related]  

  • 7. Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2.
    Williams E; Bond K; Zhang B; Putland M; Williamson DA
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32317257
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV-2 diagnostic testing in Africa: needs and challenges.
    Adebisi YA; Oke GI; Ademola PS; Chinemelum IG; Ogunkola IO; Lucero-Prisno Iii DE
    Pan Afr Med J; 2020; 35(Suppl 2):4. PubMed ID: 32528615
    [No Abstract]   [Full Text] [Related]  

  • 9. Real-time RT-PCR in COVID-19 detection: issues affecting the results.
    Tahamtan A; Ardebili A
    Expert Rev Mol Diagn; 2020 May; 20(5):453-454. PubMed ID: 32297805
    [No Abstract]   [Full Text] [Related]  

  • 10. Nasopharyngeal swab collection in the suspicion of Covid-19.
    Piras A; Rizzo D; Longoni E; Turra N; Urru S; Saba PP; Musumano L; Bussu F
    Am J Otolaryngol; 2020; 41(5):102551. PubMed ID: 32487335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid roll out of SARS-CoV-2 antibody testing: even at high levels of specificity, an important proportion of test results will be false positives.
    Gruer L; Bhopal R
    BMJ; 2020 Jul; 370():m2910. PubMed ID: 32699002
    [No Abstract]   [Full Text] [Related]  

  • 12. The Appropriate Use of Testing for COVID-19.
    Zitek T
    West J Emerg Med; 2020 Apr; 21(3):470-472. PubMed ID: 32302278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2.
    McCormick-Baw C; Morgan K; Gaffney D; Cazares Y; Jaworski K; Byrd A; Molberg K; Cavuoti D
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32414838
    [No Abstract]   [Full Text] [Related]  

  • 14. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
    Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041
    [No Abstract]   [Full Text] [Related]  

  • 15. Validation of the Hologic Aptima Unisex and Multitest Specimen Collection Kits Used for Endocervical and Male Urethral Swab Specimens (Aptima Swabs) for Collection of Samples from SARS-CoV-2-Infected Patients.
    Avaniss-Aghajani E; Sarkissian A; Fernando F; Avaniss-Aghajani A
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32317256
    [No Abstract]   [Full Text] [Related]  

  • 16. Special Issue on Diagnostic Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Lessons from This Pandemic.
    McAdam AJ
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703896
    [No Abstract]   [Full Text] [Related]  

  • 17. How should a positive PCR test result for COVID-19 in an asymptomatic individual be interpreted and managed?
    Esteve C; Catherine FX; Chavanet P; Blot M; Piroth L
    Med Mal Infect; 2020 Nov; 50(8):633-638. PubMed ID: 33022291
    [No Abstract]   [Full Text] [Related]  

  • 18. Shifting sands-Molecular coronavirus testing during a time of inconsistent resources.
    Henderson DK; Hayden MK; Wright SB; Weber DJ; Murthy AR; Babcock H; Guzman-Cottrill JA; Haessler S; Rock C; Van Schooneveld T; Forde CA; Logan LK; Malani A;
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1190-1191. PubMed ID: 32498736
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety considerations in the bioanalytical laboratories handling specimens from coronavirus disease 2019 patients.
    Chen Z; Sikorski TW
    Bioanalysis; 2020 Sep; 12(17):1219-1222. PubMed ID: 32820941
    [No Abstract]   [Full Text] [Related]  

  • 20. The Brief Case: "Not Positive" or "Not Sure"-COVID-19-Negative Results in a Symptomatic Patient.
    Parikh BA; Bailey TC; Lyons PG; Anderson NW
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.